Further investigation into the molecular subgroups of GBM showed that TP53 mutation is indicative of mutations on additional genes and that IDH1-mutated GBM tumors lack EGFRvIII mutations and are more likely to carry TP53 mutation and MGMT promoter methylation. The gene discussed is MGMT; the disease is glioblastoma.